Gyre Therapeutics
Price & Volume
Stats
See more52W Range | $6.11-$14.42 |
Market Cap | $738.8M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $107.2M |
Revenue Growth (YoY) | 19.9% |
Gross Profit (12 Mos) | $102.4M |
Diluted EPS | $0.04 |
News
See moreYahoo Finance • 27 days ago
Gyre Therapeutics Reports Third Quarter 2025 and Year-to-Date Financial Results and Provides Business Update
Yahoo Finance • 2 months ago
Gyre Therapeutics Announces Completion of Patient Enrollment in Phase 3 Clinical Trial of Pirfenidone Capsules for the Treatment of Pneumoconiosis
Yahoo Finance • 2 months ago
Gyre Therapeutics to Present Results from Positive Phase 3 Clinical Trial Evaluating Hydronidone for the Treatment of Liver Fibrosis in Chronic Hepatitis B at AASLD—The Liver Meeting® 2025
Yahoo Finance • 3 months ago
Gyre Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
About
CEO | Mr. Ping Zhang |
Address | 12770 High Bluff Drive, San Diego, CA, United States, 92130 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 579 |
